BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27915433)

  • 1. Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?
    Habraken V; van Nijnatten TJ; de Munck L; Moossdorff M; Heuts EM; Lobbes MB; Smidt ML
    Breast Cancer Res Treat; 2017 Feb; 161(3):483-489. PubMed ID: 27915433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNM classification and the need for revision of pN3a breast cancer.
    van Nijnatten TJA; Moossdorff M; de Munck L; Goorts B; Vane MLG; Keymeulen KBMI; Beets-Tan RGH; Lobbes MBI; Smidt ML
    Eur J Cancer; 2017 Jul; 79():23-30. PubMed ID: 28458119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure.
    Verheuvel NC; Voogd AC; Tjan-Heijnen VCG; Siesling S; Roumen RMH
    Breast Cancer Res Treat; 2017 Oct; 165(3):555-563. PubMed ID: 28656490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases.
    Heuts EM; van der Ent FW; Hulsewé KW; von Meyenfeldt MF; Voogd AC
    Breast; 2009 Aug; 18(4):254-8. PubMed ID: 19515565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
    Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
    Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracapsular extension in the positive sentinel lymph node: a marker of poor prognosis in cT1-2N0 breast cancer patients?
    Vane MLG; Willemsen MA; van Roozendaal LM; van Kuijk SMJ; Kooreman LFS; Siesling S; de Wilt HHW; Smidt ML
    Breast Cancer Res Treat; 2019 Apr; 174(3):711-718. PubMed ID: 30610488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study.
    Tvedskov TF; Jensen MB; Ejlertsen B; Christiansen P; Balslev E; Kroman N
    Breast Cancer Res Treat; 2015 Oct; 153(3):599-606. PubMed ID: 26341752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
    Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
    Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
    Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
    Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
    Ma X; Yang X; Yang W; Shui R
    Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study.
    Madsen EV; Aalders KC; van der Heiden-van der Loo M; Gobardhan PD; van Oort PM; van der Ent FW; Rutgers EJ; Valdés Olmes RA; Elias SG; van Dalen T
    Ann Surg Oncol; 2015 Dec; 22(13):4254-62. PubMed ID: 25808100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?
    Rosenberger LH; Ren Y; Thomas SM; Greenup RA; Fayanju OM; Hwang ES; Plichta JK
    Breast Cancer Res Treat; 2020 Feb; 179(3):661-670. PubMed ID: 31741179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
    Poodt IGM; Rots ML; Vugts G; van Dalen T; Kuijer A; Vriens BEPJ; Nieuwenhuijzen GAP; Schipper RJ
    Eur J Surg Oncol; 2018 Aug; 44(8):1151-1156. PubMed ID: 29580733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.